Pharma Grade Cellulose Powder Market Trends And Growth Drivers Point To Strong Future Potential
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Pharma Grade Cellulose Powder Market CAGR Analysis And Future Market Development
The market for pharma grade cellulose powder has experienced robust expansion in recent years. Valued at $1.55 billion in 2025, it is projected to reach $1.65 billion by 2026, reflecting a compound annual growth rate (CAGR) of 6.1%. This historic growth has been driven by several factors, including the rising prevalence of oral drug formulations, the extensive utilization of cellulose as an excipient, the scaling up of pharmaceutical production, an increasing need for formulation stability, and the regulatory endorsement of cellulose-based excipients.
The pharmaceutical-grade cellulose powder market is projected to experience robust expansion in the coming years, reaching an estimated $2.09 billion by 2030 with a compound annual growth rate of 6.1%. This anticipated growth during the forecast period is driven by factors such as the rising use of cellulose in nutraceuticals, an increased preference for clean-label excipients, the broadening of generic drug portfolios, innovations in excipient engineering, and a greater push toward sustainability. Key developments shaping the forecast period include a growing demand for plant-derived pharmaceutical excipients, heightened utilization in solid oral dosage forms, a surge in the adoption of microcrystalline cellulose, the expansion of multifunctional cellulose-based excipients, and an intensified emphasis on sustainable sourcing of these materials.
Download A Free Sample Report For Comprehensive Market Insights:
Pharma Grade Cellulose Powder Market Growth Factors Supporting Long-Term Expansion
The anticipated growth in pharmaceutical manufacturing is set to advance the market for pharma-grade cellulose powder in the coming years. This manufacturing process encompasses the creation of medicines through the formulation, synthesis, and quality testing of active ingredients and excipients, prioritizing safety, efficacy, and adherence to regulatory standards. A surge in chronic diseases, which demand ongoing and prolonged medication for proper management, is fueling higher levels of pharmaceutical production. Within this context, pharma-grade cellulose powder serves as a crucial binder, filler, and stabilizer, preserving tablet structure and guaranteeing consistent distribution of active compounds. As an illustration, data from June 2023 released by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade body based in Belgium representing Europe’s pharmaceutical sector, indicated that total pharmaceutical output in Europe reached $422,803 million (€390,000 million) in 2023, compared to $393,857 million (€363,300 million) in 2022. Consequently, the expansion of pharmaceutical production is propelling the pharma-grade cellulose powder market forward.
Pharma Grade Cellulose Powder Market Segment Analysis: What Are The Major Market Categories?
The pharma grade cellulose powder market covered in this report is segmented –
1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)
2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent
3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications
4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries
Subsegments:
1) By Microcrystalline Cellulose: Powder, Granules
2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants
3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)
4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)
Pharma Grade Cellulose Powder Market Industry Trends Shaping Future Revenue Growth
Key players in the pharma-grade cellulose powder market are prioritizing the establishment of new microcrystalline cellulose facilities as a strategy to boost production capacity and reinforce their supply chain capabilities for pharmaceutical excipients. Such a facility is a specialized plant where purified cellulose undergoes controlled chemical and mechanical processes to yield uniform, fine-grade particles intended for pharmaceutical applications. As an example, in September 2023, Nitika Pharmaceuticals Specialties, an excipient manufacturer based in India, launched Tabcell, the country’s largest microcrystalline cellulose (MCC) production plant, located in Nagpur. This facility, featuring advanced technology and an installed capacity of 1200 metric tons, was inaugurated by Union Minister Nitin Gadkari and represents a major achievement under the Indian government’s Production Linked Incentive (PLI) scheme for excipients. The new plant enhances Nitika Pharma’s standing as a global frontrunner in pharmaceutical excipients, catering to both domestic demand and exports to over 92 countries, while simultaneously advancing the “Make in India” campaign and creating substantial employment opportunities.
Pharma Grade Cellulose Powder Market Leading Companies Driving Competitive Growth
Major companies operating in the pharma grade cellulose powder market are Roquette Frères, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.
Access The Complete Pharma Grade Cellulose Powder Market Report:
Pharma Grade Cellulose Powder Market Regional Analysis And Leading Geography
North America was the largest region in the pharma-grade cellulose powder market in 2025. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
